Shotgun metaproteomics of the human distal gut microbiota. Present by Lei Chen

Similar documents
Symposium on Protein Fractionation

The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.

for the Identification of Phosphorylated Peptides

Shotgun Proteomics MS/MS. Protein Mixture. proteolysis. Peptide Mixture. Time. Abundance. Abundance. m/z. Abundance. m/z 2. Abundance.

Glycosylation analysis of blood plasma proteins

Proteomics of body liquids as a source for potential methods for medical diagnostics Prof. Dr. Evgeny Nikolaev

Learning Objectives. Overview of topics to be discussed 10/25/2013 HIGH RESOLUTION MASS SPECTROMETRY (HRMS) IN DISCOVERY PROTEOMICS

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook

Enhancing Sequence Coverage in Proteomics Studies by Using a Combination of Proteolytic Enzymes

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

HUMAN GUT MICROBIOTA

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy

Proteome analysis Cellular proteomics Plasma proteomics

Gut microflora and estrogens: a new paradigm for breast cancer risk reduction. Dr. Kathleen Egan (Moffitt) Dr. Lusine Yaghjyan (UF)

Figure S6. A-J) Annotated UVPD mass spectra for top ten peptides found among the peptides identified by Byonic but not SEQUEST + Percolator.

Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan

Introduction to Proteomics 1.0

Protein Reports CPTAC Common Data Analysis Pipeline (CDAP)

Microbiome as a marker for CRC screening

Are microbes the missing piece of the gut comfort puzzle?

The Gut Microbiome: 101 Justin Carlson University of Minnesota

Diet, Microbiome and Health Cindy D. Davis

The distribution of log 2 ratio (H/L) for quantified peptides. cleavage sites in each bin of log 2 ratio of quantified. peptides

Probing the water flea's biochemistry: a truly complex but high information content environmental sample

The Impact of Column Peak Capacity on the Multi- dimensional Chromatography of Complex Peptide Mixtures

REDOX PROTEOMICS. Roman Zubarev.

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

Bio Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease

PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

INTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES

New Insights on the Structure of the Human Gut Microbiota. Chaysavanh Manichanh, PhD Vall d Hebron Research Institute Barcelona

NIH Public Access Author Manuscript J Proteome Res. Author manuscript; available in PMC 2014 July 05.

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute

APPLICATION NOTE. Highly reproducible and Comprehensive Proteome Profiling of Formalin-Fixed Paraffin-Embedded (FFPE) Tissues Slices

Corporate Medical Policy

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

Quantification with Proteome Discoverer. Bernard Delanghe

Digitizing the Proteomes From Big Tissue Biobanks

Human intestinal microbiology and probiotics

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know

Microbial Adaptations of the Microbiome. Damian R. Plichta, PhD Director of Bioinformatics

Protein and peptide separations,

PROBIONA. PROBIOTICS with 5 bacterial strains. Suitable during and after the use of antibiotics to restore intestinal microflora.

PTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System

The impact of the microbiome on brain and cognitive development

Quantitative LC/LC/MS/MS of Mixed Proteomes Application to Studies of Human Infectious Disease and Bacterial Endosymbionts

4.2 RESULTS AND DISCUSSION

Mark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions

Consistent and Reproducible Production of a Microbiota-based Drug for Recurrent C. difficile

Supplementary Figures and Notes for Digestion and depletion of abundant

Understanding probiotics and health

Development of a Human Cell-Free Expression System to Generate Stable-Isotope-Labeled Protein Standards for Quantitative Mass Spectrometry

Analysis of the effect of probiotics on shaping human gut microbiota

Mass Spectrometry and Proteomics - Lecture 4 - Matthias Trost Newcastle University

Matched Analysis of Differences of Microbiomes in Japanese vs. Non-Japanese Patients from an Ulcerative Colitis Study

The Gut Microbiome: What Do We Know?

Gut Microbiome Essentials

Molecular Cell, Volume 46. Supplemental Information

Next generation of probiotics

Faecalibacterium prausnitzii

Ever wonder what s really happening on the inside?

Examining the effects of pre and probiotics on gut microbiota during the ageing process

Overview of the Microbiome in Health and Disease Cindy D. Davis

Immunity & Metabolism Human Microbiome Systems Nutrition. Food Bioactives Asian Consumers

4th Multidimensional Chromatography Workshop Toronto (January, 2013) Herman C. Lam, Ph.D. Calibration & Validation Group

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

About the Editors List of Contributors

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota

Real time connection of Mass Spectrometry with Medicine and Surgery

Microbiome and Asthma

Health Benefits of Prebiotic Dietary Fiber

Nature Methods: doi: /nmeth.3177

Characterization of an Unknown Compound Using the LTQ Orbitrap

Teacher Resource for: Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice.

Bacteriology. Mycology. Patient: REDOX Biomedicine Co., Ltd. Referring Laboratory Attn Alan Ou 5F, No. 369, Song Jiang Road Taipei, Taiwan

Laboratory report. Test: Leaky gut test. Sample material: stool. John Doe Main St 1 Anytown

FIBRE; IT S WHAT S FOR DINNER GUT HEALTH. A NEW PARADIGM IN MONOGASTRIC NUTRITION

Quantitative chromatin proteomics reveals a dynamic histone. post-translational modification landscape that defines asexual

Bacteriology. Mycology. Genova Diagnostics SAMPLE REPORT. Rare. Rare. Negative. Brown. Negative *NG. Negative

Nature Biotechnology: doi: /nbt Supplementary Figure 1

Metabolite identification in metabolomics: Metlin Database and interpretation of MSMS spectra

Human Microbiome Research at NIH: Past, Present & Future

New Mass Spectrometry Tools to Transform Metabolomics and Lipidomics

Bacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative

Stool Testing for the Microbiome - Ready for Primetime?

Ion Source. Mass Analyzer. Detector. intensity. mass/charge

Supplemental Information. Host-Microbiota Interactions in the Pathogenesis. of Antibiotic-Associated Diseases

Corporate Medical Policy Fecal Microbiota Transplantation

9/25/2018 COPE WEBINAR SERIES FOR HEALTH PROFESSIONALS DID YOU USE YOUR PHONE TO ACCESS THE WEBINAR?

2200 GI Effects Comprehensive Profile Stool Interpretation At-a-Glance

Supporting Information. Lysine Propionylation to Boost Proteome Sequence. Coverage and Enable a Silent SILAC Strategy for

Diet-microbiome-health interactions in older people

Advances in Hybrid Mass Spectrometry

WEBINAR Microbial Metabolism Associated with Health. 12 April 2018; CET

Supporting Information

Transcription:

Shotgun metaproteomics of the human distal gut microbiota Present by Lei Chen (lc6@indana.edu)

Outline Background What are the goals? Materials and Methods Results Discussion

Background The human gastrointestinal (GI) tract is host for myriads of microorganisms Each human has a unique and relatively stable gut microbiota The composition of the GI microbiota is linked to inflammatory bowel diseases 80% of gut microbial species have not yet been isolated or characterized Vast microbial diversity with largely unknown function that is waiting to be explored

What are the goals To directly identify microbial proteins in fecal samples To identify the range and types of proteins To assign putative functions to unknown proteins that are not covered by COGs To obtain a first large-scale glimpse of the functional activities of the microbial community residing in the human gut

Materials and Methods Fecal Sample Collection Female healthy monozygotic twin 6a and 6b The only difference is that individual 6b had taken nonsteroidal anti-inflammatory drugs for a year Fecal Samples were carefully collected and safely stored The Uppsala County Ethics Committee and the Oak Ridge National Laboratory (ORNL) human study review panel approved the study.

Materials and Methods Microbial cell extraction from fecal samples Fecal samples were thawed at +4 C and microbial cells were extracted from the bulk fecal material by differential centrifugation The resulting bacterial cell pellets were immediately frozen at 70 C and stored until use.

Materials and Methods Cell lysis and protein extraction from cell pellets The microbial cell pellets were processed through single tube cell lysis and protein digestion. For each LC-MS/MS analysis below, 1/4 of the total sample was used.

Materials and Methods 2D-LC-MS/MS Both samples were analyzed in technical duplicates through a 2D nano-lc MS/MS system with a split- phase column (RP-SCX-RP) (McDonald et al., 2002) on a LTQ Orbitrap (ThermoFisher Scientific, San Jose, CA, USA) with 22h runs per sampl Liquid chromatography-mass spectrometry (LC-MS, or alternatively HPLC-MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analysis capabilities of mass spectrometry.

Materials and Methods 2D-LC-MS/MS LC-MS is a powerful technique used for many applications which has very high sensitivity and specificity. Generally its application is oriented towards the specific detection and potential identification of chemicals in the presence of other chemicals (in a complex mixture).

Materials and Methods Proteome informatics All MS/MS spectra were searched with the SEQUEST algorithm (Eng et al., 1994) and filtered with DTASelect/ Contrast (Tabb et al., 2002) at the peptide level (Xcorrs of at least 1.8 ( þ 1), 2.5 ( þ 2), 3.5( þ 3)). SEQUEST: Algorithm developed for MS-MS fragmentation identification by J. Eng (1994) in John Yates Lab (Scripps, U Wash) SEQUEST is a database search program distributed by Finnigan Corp.

Materials and Methods SEQUEST Database The first database (db1) contained two human subject metagenomes The second database (metadb), Bacteroides genome sequences plus other sequences from representatives of the normal gut microbiota The third and fourth database were made by reversing or randomizing the db1 and appending it on the end of db1 in order to determine false positive rates

Materials and Methods Hypothetical protein prediction Hypothetical proteins were submitted to the distant homology recognition server FFAS03 For 80% of the hypothetical proteins, a statistically significant match (Z-score below 9.5) to one of the proteins in the reference databases was obtained. Functions of the matching proteins were used to assign a provisional function for the hypothetical proteins identified in this study.

Result Metaproteomics of fecal samples 1822 redundant and 1534 non-redundant proteins from searching the first database (db1) 1/3 matched human proteins, 2/3 matched predicted proteins from the microbial metagenome sequence data From the metadb, the total number of proteins identified were 2911 redundant and 2214 non-redundant. Including all the proteins in db1

Result Metaproteomics of fecal samples

Result Metaproteomics of fecal samples 30 35% of spectra matched to the human protein database, most likely due to a few highly abundant human proteins in the samples with a large number of spectral counts. Rice and environmental isolate distracters were low, between 2 and 9% Of the 10 000 13 000 total spectra observed from each run, 2000 matched Bacteriodes or Bifidobacterium species.

Result COG categories in the gut metaproteome False-positive rate at the peptide level of1 5% for all identified peptides COG categories in the gut metaproteome:

Result COG categories in the gut metaproteome

Result Label-free estimation of relative protein abundance Relative abundances estimation by calculating normalized spectral abundance factors (NSAF) This approach takes into account the sample-to-sample variation that is obtained when carrying out replicate analyses of a sample and the fact that longer proteins tend to have more peptide identifications than shorter proteins. The technical runs were highly reproducible for a given sample; R^2 values of 0.77 and 0.85 for samples 7 and 8, respectively

Result Label-free estimation of relative protein abundance The most abundant proteins based on this prediction were common abundant human-derived digestive proteins such as elastase, chymotrypsin C and salivary amylases. The most abundant microbial proteins included those for expected processes, such as enzymes involved in glycolysis Ribosomal proteins (in particular for Bifidobacterium) were also relatively abundant

Result Label-free estimation of relative protein abundance The gut microbiomes previously published were enriched for many COGs representing key genes in the methanogenic pathway, consistent with H2 removal from the distal gut ecosystem through methanogenesis. By contrast, They found very few. Butyrate kinase was the most highly enriched COG in the previous metagenomic study by Gill et al. (2006). However, They did not identify butyrate kinase. butyryl-coa dehydrogenase was strongly expressed in sample 8 but was not detected in sample 7.

Result Label-free estimation of relative protein abundance A high proportion of these proteins were from common gut bacteria (Bacteroides, Bifidobacterium and Clostridium) and represented housekeeping functions: Translation (19%) Energy production (14%) Posttranslational modification and protein turnover(12%) Carbohydrate metabolism (16%) The proteins present or overrepresented in only one sample could represent bacterial populations and functions that change according to environmental influences, such as immediate diet.

Result Analysis of unknown hypothetical proteins 116 unknown proteins from the published metagenomes and 89 from bacterial isolate genomes The majority of unknown proteins belonged to novel protein families that are over-represented in genomes of gut microbes

Result Identification of human proteins Almost 30% of all identified proteins were human. digestive enzymes,structural cell adhesion and cell cell interaction proteins and innate immunity proteins Most of the abundant human proteins were similar in the two individuals Uniform distribution of DBMT1

Discussion The first demonstration of an approach for obtaining metaproteomics datasets from complex environment The gut microbiota represents a highly diverse community with thousands of species it was feasible to use an unmatched metagenome dataset to obtain valid protein identifications A wealth of information about functional pathways and microbial activities could be gleaned from this data,

Questions

Thank You